LGALS3 and hydrops fetalis: Plasma GAL-3 was 14±4 ng/mL in control patients without HF and was elevated in patients with stable (21±11 ng/mL) and decompensated (23±12 ng/mL) HFrEF and in patients with stable (23±9 ng/mL) and decompensated (22±10 ng/mL) HFpEF (P<0.05 versus control patients without HF for all).